SAN DIEGO—(BUSINESS WIRE)—May 24, 2007—ACADIA PharmaceuticalsInc. (Nasdaq:ACAD), a biopharmaceutical company utilizing innovativetechnology to fuel drug discovery and clinical development of noveltreatments for central nervous system disorders, today announced thatit will present at the following investor conferences:
—The Bank of America 2007 Health Care Conference on Thursday,May 31, 2007, at 9:20 a.m. Pacific Time at the Four SeasonsHotel in Las Vegas.—The Sixth Annual Needham & Company Biotechnology and MedicalTechnology Conference on Wednesday, June 13, 2007, at 8:30a.m. Eastern Time at The New York Palace Hotel in New YorkCity.—The Jefferies Healthcare Conference on Wednesday, June 27,2007, at 2:00 p.m. Eastern Time at the Mandarin Oriental Hotelin New York City.
Live webcasts of these presentations will be accessible on thecompany's website, www.acadia-pharm.com, under the investors sectionand an archived recording will be available on the website for twoweeks following the presentation.
About ACADIA Pharmaceuticals
ACADIA is a biopharmaceutical company utilizing innovativetechnology to fuel drug discovery and clinical development of noveltreatments for central nervous system disorders. ACADIA currently hasfive mid-to-late stage clinical programs as well as a portfolio ofpreclinical and discovery assets, directed at diseases with largeunmet medical needs, including schizophrenia, Parkinson's diseasepsychosis, sleep maintenance insomnia, and neuropathic pain. All ofthe drug candidates in ACADIA's product pipeline emanate fromdiscoveries made using its proprietary drug discovery platform.ACADIA's corporate headquarters is located in San Diego, Californiaand it maintains research and development operations in both San Diegoand Malmo, Sweden.
CONTACT: ACADIA Pharmaceuticals Inc.
Lisa Barthelemy, Director, Investor Relations
Thomas H. Aasen, Vice President and
Chief Financial Officer
858-558-2871